SureTrader SureTrader
Home > Boards > US OTC > Cannabis >

Medicine Man Technologies Inc. (MDCL)

MDCL RSS Feed
Add MDCL Price Alert      Hide Sticky   Hide Intro
Moderator: mick, Drugdoctor, dorismd2001
Search This Board:
Last Post: 12/1/2016 6:11:04 AM - Followers: 39 - Board type: Free - Posts Today: 0
 

Cannabis Licensing & Consulting

WEBSITE LINKS: http://www.medicinemandenver.com/

 
http://www.medicinemantechnologies.com/

http://www.medicinemantechnologies.com/cultivation-operations-cannabis-technology.html

http://www.medicinemantechnologies.com/media-news.html


 

Medicine Man Technologies Inc. Signs Ten New Clients in October, Reaffirms Acquisitions Status, and Successfully Raises Funds for Support of Continued Growth

ACCESSWIRE via CMTX - Fri Oct 21, 8:13AM CDT

DENVER, CO / ACCESSWIRE / October 21, 2016 / Medicine Man Technologies Inc. (OTCQB:MDCL), one of the country's leading cannabis branding and consulting companies announced yesterday via an 8K filing that it has added eight new licensing clients in October including five in Pennsylvania, two in Puerto Rico, and one in Florida. It further noted the addition of two clients in California under its new Cultivation MAX services product bringing the total new clients added in October to ten. Within that 8K the Company also noted a status update on its previously announced acquisitions as well as a successful funding initiative close as described herein.

Brett Roper, the Company's Co-Founder noted, "We are continuing to grow our existing client base and are very pleased to add these new groups to our existing clients in Arizona, California, Florida, Maryland, Nevada, Oregon, Ohio, Oklahoma, Ohio, Pennsylvania, Texas, and Puerto Rico."

In yesterday's 8K filing the Company noted that it had previously reported execution a binding term sheet on Aug. 12, 2016, whereby we agreed to acquire Pono Publications Ltd. ("Pono") and Success Nutrients, Inc. ("SNI"), both Colorado corporations, in consideration for the issuance of an aggregate of 7 million shares of our common stock. While we continue to negotiate the terms of a definitive agreement with Pono and SNI, and complete due diligence efforts, on Oct. 18, 2016, we executed an Interim Products and Services Support Agreement with both companies (the "Interim Agreement"). This Interim Agreement is intended to act as a "bridge" to allow us to work with both Pono and SNI to perpetuate our respective business plans and take advantage of our respective synergies during the time the definitive agreements are being completed. Through this agreement we will share net revenues with Pono and SNI, as applicable and expect to also benefit from the anticipated generation of new clients, and sharing of intellectual property.

In yesterday's 8K filing, the Company noted that it had previously reported signing a non-binding term sheet to acquire Capital G Ltd, an Ohio limited liability company and its three wholly owned subsidiary companies, Funk Sac LLC, Commodigy LLC, and OdorNo LLC, in consideration for the issuance of an aggregate of 1.3 million shares of our common stock. We believe that this transaction remains viable; however, the due diligence efforts are taking longer than expected. While we remain optimistic that this acquisition will be successful, the successful closing of this transaction is dependent on the outcome of our due diligence. As part of the terms included in the term sheet, we have fulfilled our agreement with Capital G Ltd. To provide funding for its operations over the past several months in the form of $250,000 in convertible debt. This note is for a one-year term and accrues interest at 12% per annum.

Andy Williams, the Company's CEO and Co-Founder added, "As we work to wrap up these synergistic acquisitions, we will continue to search for growth opportunities that will help expand our value proposition to our clients and partners and to add new lines of revenue through products and services that drive the evolution of the cannabis industry. We will continue to focus on building our brands warehouse to offer a more efficient delivery of marketing and corporate services. This November's election will mark the latest opportunity for the cannabis industry to expand into new states and create further opportunities for Medicine Man Technologies to help them do it."

The Company further announces that it has just launched a new product branded Cultivation MAX, wherein we are providing cultivation advisory services to existing operators desiring to increase their yields through deployment of our combined efficiencies. We anticipate revenues related to this new deployment to include design fees as well as income derived by formula arising from the anticipated improvement experienced in our client's cultivation practices. While no specific assurances can be provided, we believe this future income stream may be substantial based upon current performance levels noted in the cannabis cultivation landscape within states allowing for access of such related products.

The Company also announced that effective Friday, Oct. 14, 2016, we engaged in an initial closing of private offering of convertible notes in the aggregate amount of $500,000 from four accredited investors in which there we no fees or commissions required. Our anticipated use of proceeds of these funds will be related to 1) cost of consummating the acquisitions described herein; 2) hiring additional employees in anticipation of our continued growth; 3) additional marketing and industry presence advertising; and 4) working capital, including capital to be used in expanding our 'branding warehouse' approach to support growth.

The Company will also continue to be a Platinum level sponsor of the industry's largest conference, to be held in Las Vegas Nevada in November and as held by Marijuana Business Daily noting information for this even that can be found at https://mjbizconference.com/.

About Medicine Man Technologies

Established in March 2014, the Company secured its first client/licensee in April 2014. To date, they have provided guidance for several clients (Colorado, Nevada, and Illinois) that have successfully secured licenses to operate cannabis businesses within their state. They currently have twenty-four active clients in 13 states, focusing on working with licensees and clients to 1) utilize its experience, technology, and training to help secure a license, 2) deploy the Company's highly effective variable capacity constant harvest cultivation practices and eliminate the liability of single grower dependence, 3) avoid the costly mistakes generally made in start-up, and 4) stay engaged with an ever expanding team of licensees all focused on quality and safety that will 'share' the ever improving experience and knowledge of the network.

Safe Harbor Statement

This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues as well as any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the Securities and Exchange Commission. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to general stock market conditions. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC filings. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new service lines noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations we will be providing services in, the impact of which cannot be predicted at this time.

Contact Information:

Attention Brett Roper via info@medicinemantechnologies.com

Telephone (303) 371-0387

Website www.medicinemantechnologies.com

SOURCE: Medicine Man Technologies Inc.

http://www.accesswire.com/img.ashx?id=447455

Copyright 2016 ACCESSWIRE
 

 

Item 1.01 Entry into a Material Definitive Agreement

 

(a) We previously reported that we executed a binding term sheet on Aug. 12, 2016, whereby we agreed to acquire Pono Publications Ltd. (“Pono”) and Success Nutrients, Inc. (“SNI”), both Colorado corporations, in consideration for the issuance of an aggregate of 7 million shares of our common stock. While we continue to negotiate the terms of a definitive agreement with Pono and SNI, and complete due diligence efforts, on Oct. 18, 2016, we executed an Interim Products and Services Support Agreement with both companies (the “Interim Agreement”). This Interim Agreement is intended to act as a “bridge” to allow us to work with both Pono and SNI to perpetuate our respective business plans and take advantage of our synergy during the time the definitive agreements are being completed

 

Pono provides consulting services to the cannabis industry in Colorado and elsewhere, and includes the Three A LightTM cultivation publication. This new cultivation protocol has achieved repeated yields, verified through MetrcTM, in the 750-gram per square foot range of flowering canopy per year, and is deployable in both greenhouse and indoor cultivations.

 

The SNI brand provides one of the key underpinnings of the cultivation methodology and is essential to the overall Three A Light TM performance metric. With an investment of two years of research, development and intense testing, this product line was specifically formulated for the cannabis industry.

 

Among other things, the interim agreement allows us to:

 

  · Leverage Pono’s disruptive cultivation technology to enhance the already successful industrial operation of Medicine Man, an affiliate company, for both current and future production;
  · Engage Pono professional services and support in the deployment of their methodologies in fulfillment of our consulting agreements with our clients;
  · To have planned, reasonable access to Pono’s Colorado-based Three A LightTM grow facilities tours and support of consulting services;
  · Feature SNI as our recommended and exclusive nutrient line; and externally market the Pono and SNI names and product lines, subject to their final approval.

 

We will share net revenues with Pono and SNI, as applicable and expect to also benefit from the anticipated generation of new clients, and sharing of intellectual property.

 

A copy of the Interim Agreement is attached to this report as Exhibit 10.3, and is incorporated herein as if set forth.

 

(b) In a Form 8-K dated July 26, 2016, we reported that we had signed a non-binding term sheet to acquire Capital G Ltd, an Ohio limited liability company and its three wholly owned subsidiary companies, Funk Sac LLC, Commodigy LLC, and OdorNo LLC, in consideration for the issuance of an aggregate of 1.3 million shares of our common stock. We believe that this transaction remains viable; however, the due diligence efforts are taking longer than expected. While we remain optimistic that this acquisition will be successful, the successful closing of this transaction is dependent on the outcome of our due diligence. As part of the terms included in the term sheet, we had agreed to provide Capital G Ltd. with $250,000 in convertible debt, which we have done. This note is for a one year term and accrues interest at 12% per annum.

 

 

 

  2  

 

 

Item 8.01 Other Events

 

(a) As a result of our relationship with Pono and SNI referenced in Item 1.01, we have recently launched a new product branded Cultivation MAX, wherein we are providing cultivation advisory services to existing operators wanting to increase their yields through deployment of our combined efficiencies. As of the date of this report, we have generated our initial two clients for these services in California and are actively working with those teams to improve their cultivation practices. We anticipate revenues related to this new deployment to include design fees as well as income derived by formula arising from the anticipated improvement experienced in our client's cultivation practices.  This is generally based upon pounds per light or grams per square foot of canopy within the individual cultivation facility.  While no assurances can be provided, we believe this future income stream may be substantial based upon current performance levels noted in the cannabis cultivation landscape within states allowing for access of such related products.  This assumption is further based upon the improved performance metrics of 750 grams per square foot on an annualized basis as more fully described in section 1.01 above.

 

(b) Including the two new clients referenced in (a), above, we have generated a total of ten new clients in the month of October, 2016, alone. These new clients include three new cultivation support and two new dispensary support licensing agreements with clients in Pennsylvania, two cultivation agreements in in Puerto Rico and one new general support services agreement with a Florida-based client. This fills our available capacities in Pennsylvania when added to our existing support commitments. We expect that these agreements will generate significant new income for us through the first calendar quarter of 2017. While no assurances can be provided, we also expect new legislative initiatives in Ohio and Michigan to generate new clients, extending into the beginning of next year. In addition, we anticipate significant opportunities arising from the nine new cannabis initiatives included in state elections this November. Adoption of all, or a significant number of these initiatives, is expected to provide us with new opportunities to expand our consulting services and relationships. There are no assurances this will occur.

 

(c) Effective Friday, Oct. 14, 2016, we engaged in an initial closing of private offering of convertible notes in the aggregate amount of $500,000 from four accredited investors. Our anticipated use of proceeds of these funds will be related to 1) cost of consummating the acquisitions described in Item 1.01, above; 2) hiring additional employees in anticipation of our continued growth, including employees in the areas of facilities design, licensing and application support, and cultivation training; 3) additional marketing and industry advertising; 4) working capital, including capital to be used in expanding our ‘branding warehouse’ approach to support growth. These notes accrue interest at a rate of 12% per annum and may be converted to stock in the discretion of the lender at a price of $1.75 per share or 90% of a five date VWAP, whichever is lower. The notes mature in December 2018.

 

Item 9.01 Financial Statements and Exhibits

 

(b) Exhibits. The following exhibits are included in this report:

 

No.

 

10.3

Description

 

Interim Products and Services Support Agreement with Pono and SNI

 

 

 

  3  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  MEDICINE MAN TECHNOLOGIES, INC.
  (Registrant)
   
Dated: October 20, 2016 By: /s/ Brett Roper
    Brett Roper, 
Chief Operating Officer

 



Medicine Man Technologies (OTCQB MDCL) is an innovative provider of consulting services related to cultivation, production, and dispensary operations nationally. Currently serving 24 clients in 13 states as well as having successfully supported license applications (cultivation and dispensary) in Illinois as well as Nevada, we are now working with clients in Maryland, Hawaii, and Alaska to support applications in their respective states. Further information about MMT can be found in our S1 and 10Q/K filings.

 

A Brief History of Medicine Man Technologies

In late 2012, Andy Williams was introduced to Brett Roper and subsequent discussions revealed the substantial value of creating a new company that could "house" as well as deliver the substantial experience Medicine Man Denver had acquired over the past five years. In the spring of 2013, these two uniquely qualified businesspersons began work on what was then known as Version 1.0 of a licensing manual that was envisioned to include a unique "seed-to-sale" documentation of the business that could then become the underpinnings of any new business' entry into this space. As of this date we are now on Version 31 which is comprised of over 400 pages and growing.

 

In April of 2014, the business venture incorporated in Nevada as a 'C' Corporation under the name of Medicine Man Technologies, Inc. Since this new business is based in the advisory role space and not in the actual growing and distribution of the product, the company is currently in the process of becoming a p

 

ublic company as it continues to generate revenues through sales of consulting and licensing services. For more information on Medicine Man Technologies public filing process, please follow this link: Medicine Man Technologies - EDGAR Page

 

Team Biographies


Andy Williams

 

Andy Williams is the President and CEO of Medicine Man in Colorado.  He is veteran of the US Army, and served three years as a Cavalry Scout in the 3rd Infantry Division.  He went on to earn a Bachelor of Science degree in Industrial Engineering from the University of Southern Colorado in Pueblo, CO. Andy has worked in a wide range of manufacturing industries as an industrial engineer, and in leadership positions.  He is a lifelong entrepreneur.  In 2009 the Ogden letter was published stating the Department of Justice would not utilize their resources to prosecute those individuals following state marijuana laws. That was the call to a new opportunity in the marijuana industry for Andy and his brother, Pete Williams. In December of 2009 they launched Medicine Man with the concept of being the Costco of marijuana. Six years later Medicine Man is now a $17 million a year corporation and has branched out to assist start up marijuana companies and grow facilities across the country with their consulting company, Medicine Man Technologies. They are known as industry leaders throughout the United States.

Brett Roper

 

Mr. Roper has an extensive background in business development, having successfully 'shepherded' several Form 10 and S1 filings as well as NASDAQ up listing efforts, most recently co-founding Medicine Man Technologies, a unique cannabis business consultant and advisory service provider. Mr. Roper has a substantial amount of RE based experience, managing acquisition, interim holding, and disposition of substantial industrial properties in the 50,000 to 400,000 SF range and is active in providing design insights for cannabis related property deployment. Mr. Roper has been responsible for management of a national marketing program for a regional RE developer having relationships with SIOR, NAI, CORFAC Global, NAIOP, and other real estate organizations across the country. Mr. Roper has served in a number of advisory capacities to other pre-public and public companies including corporate development, strategic initiative refinement, business turnaround, service as an independent board member, and management of investor relations fundamentals. His extraordinary background has allowed him to become a well-rounded 'quiet advisor' to many companies as well as investors in the Cannabusiness space.

Marc Harvill

 

Mr. Harvill has a background in pharmacy operations both in the manufacturing and retail space, with more than 10 years of experience. He holds a B.A in Marketing and Spanish from PSU and an M.B.A from Washburn University. Prior to joining Medicine Man Technologies, Marc worked for one of the largest privately operated pharmacy technology companies in the country, specifically focused on training and development, hardware and software testing and quality assurance. Marc also works for a small publicly traded company in a research and operational capacity.

Matt Best

 

As Licensing Coordinator at Medicine Man Technologies, Matt is responsible for day to day management of license agreements and client relationships for the company. He holds a B.A. in Communication and Integrated Marketing Communications from the State University of New York, College at Geneseo, a small liberal arts college in Upstate New York. Prior to joining MMT in 2015, Matt worked as a Media Supervisor at TDA_Boulder, a full-service advertising agency in Boulder, CO. In this capacity, Matt oversaw the media planning and buying team and was responsible for client relationships across local, regional, and national media accounts. Matt is an avid skier and enjoys time spent within the National Parks, away from the hustle and bustle of the Mile High City.

Carrie Roberts

 

Carrie Roberts is a creative visionary with an entrepreneurial spirit. She has a Bachelor of Arts degree in Sociology and Criminal Justice from Colorado State University. She has 13+ years of entrepreneurial business experience and began the first Customer Experience Management Company focused exclusively on the cannabis industry in 2014. She has a strong business background in strategic consulting, including business planning and strategy development, as well as expertise in marketing, business development and customer experience management. As a former Colorado POST Certified law enforcement officer Carrie is on the speakers' bureau for LEAP (Law Enforcement Against Prohibition), speaking to both policy makers and the public on drug policy reform measures. She is also on the national Retail Committee for FOCUS (Foundation of Cannabis Unified Standards), an independent, non-profit, third party source for the creation of cannabis standards and monitoring of the cannabis industry.  

Pre-License Services

 

Through our pre-licensure consulting services, Medicine Man Technologies will support your efforts with regard to your state's application process with the goal of helping your team secure a state-issued operating license. Our team will review and refine your business plan and pro formas, as well as assist in the facility design and planned operation of your cultivation and/or dispensary facilities. Our proven operational experience and state-of-the-art technology has successfully distinguished our client's applications in this emerging industry.

We have experience working within both competitive and non-competitive application environments. We have navigated the application process in several states, including: Colorado, Nevada, Illinois, New York, and most recently Maryland. As each state handles the process differently, we bring a wealth of knowledge and experience in working through an application and believe in an "on the ground" approach – ensuring you receive support when it matters most.

 

Post-License Services

 

Through our post-licensure consulting services, Medicine Man Technologies will support your efforts to become operational once your team has secured a state-issued operating license. Our team and proven network of contractors will help design your facility, adopt proven standard operating procedures, and provide hands on training for your staff within a live environment.

 

Operating in this emerging industry requires experienced partners who can help you avoid the multitude of costly mistakes often encountered by cannabis startups. Medicine Man Technologies' team of consultants can help you navigate the process of becoming a successful cannabis operation while providing access to our exclusive licensure network; a group of licensed operators across the country who share in the ongoing knowledge and best practices developed in this quick changing marketplace.

 

 

Industry Leading Cannabis Cultivation Technology

Our risk-averse cannabis cultivation technology delivers consistent, high quality, high yield production within a clean-room style environment. Through our licensure services we provide standard operating procedures for all phases of commercial and industrial cannabis cultivation, from clone to counter. In addition, we provide hands-on training and development for your personnel both at Medicine Man Denver and your facility once operational.

 

Medicine Man Technologies has experience in all areas of cannabis cultivation including: Cloning, Propagation, Vegetative and Flowering husbandry, Drying and Cure techniques utilizing what we call a VCCH model, or Variable Capacity Continuous Harvest model. Our expert team of consultants possess an extensive knowledge of cannabis plant metabolism and physiology, indoor grow protocols and best practices, and the processing of the harvested crop. We can help your legal cannabis cultivation and associated operation overcome challenges to become a market leader.

 

Medical and Recreational Cannabis Dispensary Operations

Our state-of-the art dispensary model ensures patients and consumers have safe and secure access to a variety of medical and/or recreational cannabis products. Through our licensure services we provide standard operating procedures for dispensary facilities, staffing plans, job descriptions, and hands on training for your dispensary personnel at Medicine Man Denver and your facility once operational.

Our proprietary Dispensary Manual includes the following guidance and documented best practices to help you launch, manage, and grow a successful cannabis dispensary:

  • Organizational operations manual
    Products and services
    Employee handbook
    Emergency procedures
    Standard operating procedures
    Opening / closing protocols
    Customer / patient interactions
    Inventory Control System
    Shipping and Receiving Products
    Product Recalls
    Security
    Patient Record Keeping
    Dispensary Point of Sale (POS)
    ID Requirements and Best Practices
    Visitor Logs
    Pricing Guidance
 

 

 

Turnkey Cannabis Solutions

Follow us on:

Follow Medicine Man Technologies  on Facebook Follow Medicine Man Technologies  on Instagram Follow Medicine Man Technologies  on Twitter Follow Medicine Man Technologies on YouTube
 

Copyright © 2016 | Medicine Man Technologies | All Rights Reserved |  Small business website design by Colorado Internet Solutions |  Privacy | Site Map

 
 
 
 
 

 

MDCL-is-Platinum-SPONSOR-of-Huge-VEGAS-Annual- Marijuana-Business-Conference - starting 1 week after the ELECTIONS

Here is the page with Sponsors listed at the bottom.. 

https://mjbizconference.com/ 

Here's the link to $MDCL booth 415 - Be sure to locate their FULL SIZED Display area and click on the VIDEOS they have loaded for all to see! 

http://s15.a2zinc.net/clients/MJBiz/MBCE.Fall.16/Public/Eventmap.aspx?shExhList=1&shMode=E 


 

 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MDCL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
MDCL News: Initial Statement of Beneficial Ownership (3) 11/30/2016 02:42:08 PM
MDCL News: Statement of Changes in Beneficial Ownership (4) 11/22/2016 01:13:27 PM
MDCL News: Initial Statement of Beneficial Ownership (3) 11/21/2016 09:55:50 AM
MDCL News: Quarterly Report (10-q) 11/14/2016 04:10:39 PM
MDCL News: Small Company Offering and Sale of Securities Without Registration (d) 10/21/2016 09:04:49 AM
PostSubject
#314  Sticky Note MDCL has been named one of 10 Most-Important-Companies-in-the-Cannabis-Industry!!! dorismd2001 11/18/16 10:42:33 AM
#199  Sticky Note $MDCL(OTCQB)Medicine-Man-Tech-(Marijuana-Colorado)-INVESTOR-INFO-and-DUE- DILIGENCE-links Drugdoctor 11/06/16 09:52:27 AM
#390   Trump on States Rights for Marijuana - link... Drugdoctor 12/01/16 06:11:04 AM
#389   Nice buying action today - won't be below Drugdoctor 11/30/16 12:30:11 PM
#388   Oh yea, I'm adding all I can down Drugdoctor 11/29/16 12:01:16 PM
#387   Patiently waiting! $MDCL TURCH 11/29/16 11:57:46 AM
#386   Today's action is light, no sellers left down Drugdoctor 11/29/16 11:38:53 AM
#385   Yes, some nice part: dorismd2001 11/28/16 10:25:34 PM
#384   $MDCL 3 Months Chart http://www.stockscores.c $Pistol Pete$ 11/27/16 09:44:21 PM
#383   Nice read for $MDCL - Medicine Man as Drugdoctor 11/27/16 09:17:10 PM
#382   If $MDCL signed 10 new clients in Oct., Drugdoctor 11/27/16 09:53:32 AM
#381   $MDCL 3 Months Chart http://www.stockscores.c $Pistol Pete$ 11/26/16 01:58:38 PM
#380   We have $3.00 asking price now - hope Drugdoctor 11/25/16 11:11:12 AM
#379   Yes, and I think back over $3 tomorrow, Drugdoctor 11/24/16 07:46:10 PM
#378   Nice rebound taubytaub 11/23/16 01:42:00 PM
#377   Thanks PETE - really nice reversal bar printing Drugdoctor 11/23/16 12:27:23 PM
#376   $MDCL One Month Chart http://www.stockscores. $Pistol Pete$ 11/23/16 12:23:11 PM
#375   I've been adding some shares today... get 200 Drugdoctor 11/23/16 12:03:41 PM
#374   Yes-Here's-the-link, VERY EXCITING - Wow- how many STATES Drugdoctor 11/23/16 11:46:04 AM
#373   Very exciting info!, where did you find this? dorismd2001 11/23/16 11:04:48 AM
#372   Did you see this about Medicine Man? Drugdoctor 11/23/16 10:58:58 AM
#371   Weed stocks reversing hard today! Many up Drugdoctor 11/23/16 10:33:02 AM
#370   many more weeks ahead but there will be TrendTrade2016 11/23/16 09:48:49 AM
#369   Once again, the 2013 retrace after the legalization Drugdoctor 11/23/16 09:46:27 AM
#368   Been there trend 2014 mj crush Still holding those heavy Quokkie 11/23/16 09:39:39 AM
#367   Picking bottoms in a sector like the mj TrendTrade2016 11/23/16 04:18:14 AM
#366   I think $MDCL is in a quiet period, Drugdoctor 11/22/16 05:49:20 PM
#365   Bottom out! dorismd2001 11/22/16 10:47:42 AM
#364   Yep, whole sector seems to have bottomed today, Drugdoctor 11/22/16 10:39:16 AM
#363   Added 2.5's im done too! locked up, wait TURCH 11/22/16 10:35:12 AM
#362   Ok, made my last buys in the $2.20 Drugdoctor 11/22/16 10:31:43 AM
#361   LOL - not here... $MDCL posted NET PROFITS Drugdoctor 11/22/16 10:08:27 AM
#360   Pennies coming taubytaub 11/22/16 10:00:01 AM
#359   i think so. just don't want it to TrendTrade2016 11/22/16 08:54:08 AM
#358   Do you think 50 day moving average may Drugdoctor 11/22/16 08:49:56 AM
#357   chart tells the tale every time. it has TrendTrade2016 11/22/16 08:44:25 AM
#356   Technical Chart Alert! 50 day moving average at Drugdoctor 11/22/16 08:32:34 AM
#355   re"Possible next bottom at 3.08" Drugdoctor 11/22/16 07:35:46 AM
#354   Don't say I didn't warn you TrendTrade2016 11/22/16 05:46:42 AM
#353   The day to realize MDCL's ambition to uplist dorismd2001 11/21/16 08:28:04 PM
#352   NYSE Becomes First Major Exchange To List Cannabis dorismd2001 11/21/16 08:16:15 PM
#351   Yes, the selling shares came from retailer weak dorismd2001 11/21/16 06:05:48 PM
#350   Yea, it does seem there is a seller Drugdoctor 11/21/16 05:36:09 PM
#349   Keeps dumping taubytaub 11/21/16 02:59:36 PM
#348   Nice to see CFO has a nice position Drugdoctor 11/21/16 01:00:11 PM
#347   Right... k Drugdoctor 11/20/16 09:11:03 PM
#346   Cultivation Max combined with Success Nutrients is money dorismd2001 11/20/16 08:10:12 PM
#345   Possible next bottom at 3.08 TrendTrade2016 11/20/16 03:22:33 PM
#344   Unfortunately no move to the upside for sometime TrendTrade2016 11/20/16 03:19:18 PM
#343   EXACTLY! Buy quality companies like $MDCL before Drugdoctor 11/20/16 03:15:34 PM
#342   The bull market of the MJ sector in dorismd2001 11/20/16 03:11:13 PM
#341   As More States Legalize Marijuana, Investors-And-Marketers-Line-Up Drugdoctor 11/20/16 02:58:05 PM
PostSubject